135 related articles for article (PubMed ID: 7522000)
1. [Screening test for prostate cancer].
Imai K; Kubota Y; Yamanaka H
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1923-7. PubMed ID: 7522000
[TBL] [Abstract][Full Text] [Related]
2. [Comparison between 2 techniques of screening for prostatic carcinoma. Rectal exploration and transrectal ultrasonography vs. prostate specific antigen].
Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M
Radiol Med; 1994 Oct; 88(4):453-7. PubMed ID: 7527916
[TBL] [Abstract][Full Text] [Related]
3. [Screening examination for prostate cancer. Early detection and mass screening].
Imai K; Yamanaka H
Nihon Hinyokika Gakkai Zasshi; 1993 Jul; 84(7):1175-87. PubMed ID: 7689120
[TBL] [Abstract][Full Text] [Related]
4. Normal range prostate-specific antigen versus age-specific prostate-specific antigen in screening prostate adenocarcinoma.
el-Galley RE; Petros JA; Sanders WH; Keane TE; Galloway NT; Cooner WH; Graham SD
Urology; 1995 Aug; 46(2):200-4. PubMed ID: 7542822
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic accuracy of transrectal ultrasonography for screening of prostatic cancer].
Watanabe M; Saitoh M; Watanabe H
Hinyokika Kiyo; 1996 Oct; 42(10):763-6. PubMed ID: 8951472
[TBL] [Abstract][Full Text] [Related]
6. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
[TBL] [Abstract][Full Text] [Related]
7. [Measurement of serum PSA by DELFIA PSA kit and its application for mass screening. The Gunma Urological Oncology Study Group].
Imai K; Watanabe K; Higashi H; Shinya H; Okamura K; Matsuo Y; Yazima H; Takezawa Y; Yamanaka H
Hinyokika Kiyo; 1993 Sep; 39(9):807-12. PubMed ID: 7692709
[TBL] [Abstract][Full Text] [Related]
8. [Local screening program for prostate cancer].
Kotsev R; Kolev N; Stratev S; Mikhailov O
Khirurgiia (Sofiia); 2000; 56(5-6):52-4. PubMed ID: 11692936
[TBL] [Abstract][Full Text] [Related]
9. An evaluation of usefulness of prostate specific antigen and digital rectal examination in the diagnosis of prostate cancer in an unscreened population:experience in a Nigerian teaching hospital.
Ojewola RW; Tijani KH; Jeje EA; Ogunjimi MA; Anunobi CC; Adesanya AO
West Afr J Med; 2013; 32(1):8-13. PubMed ID: 23613288
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic significance of prostate specific antigen and the development of a mass screening system for prostate cancer.
Imai K; Ichinose Y; Kubota Y; Yamanaka H; Sato J
J Urol; 1995 Sep; 154(3):1085-9. PubMed ID: 7543604
[TBL] [Abstract][Full Text] [Related]
11. Comparing two modalities of screening for prostate cancer: digital rectal examination + transrectal ultrasonography vs. prostate-specific antigen.
Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M
Tumori; 1995; 81(4):225-9. PubMed ID: 8540115
[TBL] [Abstract][Full Text] [Related]
12. Use of low free to total PSA ratio in prostate cancer screening: detection rates, clinical and pathological findings in Brazilian men with serum PSA levels <4.0 ng/mL.
Faria EF; Carvalhal GF; dos Reis RB; Tobias-Machado M; Vieira RA; Reis LO; Nogueira L; Machado RD; Freitas CH; Magnabosco WJ; Mauad EC; Carvalho AL
BJU Int; 2012 Dec; 110(11 Pt B):E653-7. PubMed ID: 22892057
[TBL] [Abstract][Full Text] [Related]
13. [Detection of cancer of the prostate. A study of 600 cases].
Teillac P; Bron J; Tobolski F; Cussenot O; Lesourd A; Leroy M; Toubert ME; Brocheriou C; Laval-Jeantet M; Le Duc A
Ann Urol (Paris); 1990; 24(1):37-41. PubMed ID: 1690963
[TBL] [Abstract][Full Text] [Related]
14. [Screening of cancer of the prostate: study in a Spanish population].
Herrero Payo JA; Montes Díaz MJ; Páez Borda A; Sánchez Sánchez E; Moreno Valle JA; Berenguer Sánchez A
Arch Esp Urol; 1996; 49(6):595-606. PubMed ID: 8929102
[TBL] [Abstract][Full Text] [Related]
15. [Mass screening for prostatic cancer].
Nakagawa S; Watanabe M; Nomoto T; Sugimoto K; Mikami K; Ebisui K; Kitamura K; Kojima M; Saitoh M; Watanabe H
Hinyokika Kiyo; 1997 Jun; 43(6):447-52. PubMed ID: 9250497
[TBL] [Abstract][Full Text] [Related]
16. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
17. Prostate cancer screening within a prostate specific antigen range of 3 to 3.9 ng./ml.: a comparison of digital rectal examination and free prostate specific antigen as supplemental screening tests.
Mäkinen T; Tammela TL; Hakama M; Stenman UH; Rannikko S; Aro J; Juusela H; Määttänen L; Auvinen A
J Urol; 2001 Oct; 166(4):1339-42. PubMed ID: 11547069
[TBL] [Abstract][Full Text] [Related]
18. [Examination of serum prostate specific antigen (PSA) in the mass screening for prostatic diseases].
Kato M; Okada K
Hinyokika Kiyo; 1993 Mar; 39(3):221-3. PubMed ID: 7685140
[TBL] [Abstract][Full Text] [Related]
19. Use of prostate-specific antigen (PSA) and PSA density in the detection of stage T1 carcinoma of the prostate.
Presti JC; Carroll PR
Semin Urol Oncol; 1996 Aug; 14(3):134-8. PubMed ID: 8865474
[TBL] [Abstract][Full Text] [Related]
20. [The role of the absolute value and "density" of the prostate-specific antigen estimated echographically in the selection of patients to undergo a biopsy in suspected prostatic carcinoma. A comparison between PSA, palpation and echography in 95 patients undergoing echo-guided endorectal prostatic biopsy].
Di Donna A; Bazzocchi M; Guerra UP; Bendini M; De Biasi F; Caminiti F; Delendi M
Radiol Med; 1993; 85(1-2):84-9. PubMed ID: 7683136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
